How to carry out treatment

摘要

The present invention relates to an improved method of administering Compound 1 therapy, which involves increasing the effect of Compound 1 by avoiding or contraindicating a concomitant CYP3A4 / P-gp inducer, such as rifampicin. [Selection diagram] Fig. 1